SkinHealth Systems Inc.
SkinHealth Systems Inc. is a U.S.-based medical aesthetics company that designs, manufactures, and sells skin-health treatment systems and related consumables. Its portfolio centers on Hydrafacial delivery systems and proprietary treatment solutions, with additional offerings in microneedling and scalp-health treatments sold through a global network of providers.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueCapital equipment used by providers to perform Hydrafacial treatments.
Recurring-use tips, solutions, and serums consumed during treatments.
Products
Reported · share of revenue- Consumables70.7 %
- Delivery Systems29.3 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
The company sells primarily to licensed providers in the professional medical and aesthetic channels, including dermatologists, plastic surgeons, medical spas, estheticians, and beauty retailers. These customers buy the systems to offer in-office skin treatments and buy consumables repeatedly as treatment volume grows. The business also reaches spas, hotels, and other retailers that use the platform to broaden service offerings.
Dermatologists, plastic surgeons, and medical practices buy systems and consumables to offer in-office aesthetic treatments.
These providers use the devices to deliver branded skin treatments and expand service menus.
Spas, hotels, and retailers buy treatments and equipment to add premium skin-health services.
Strategy
The company is focused on expanding its installed base of delivery systems and increasing utilization so consumables become a larger share of revenue. It is also investing in brand building, provider education, digital marketing, and commercial analytics to strengthen demand and retention across its platform. Product innovation in Hydrafacial, SkinStylus, and HydraScalp remains central to broadening the treatment portfolio and supporting provider economics.
More active systems create a larger recurring consumables stream and deepen provider dependence on the platform.
Consumer pull helps providers fill appointments and increases treatment frequency.
Additional treatment categories can increase wallet share within provider practices.
Geography
Q2/2026The company operates globally, with direct sales in some countries and distributor or hybrid models in others. Management disclosed that markets outside the United States and Canada represented about 35% of net sales in fiscal 2025, showing a meaningful international footprint. China is now served through a distributor partner rather than direct sales, which changes how the company reaches that market.
Share of the revenue the company reports by geography.
Risks
The business faces intense competition in a fragmented beauty and medical aesthetics market, where pricing, brand strength, and product innovation can shift quickly. It is also exposed to regulatory scrutiny over product claims, adverse events, and recalls, plus supply-chain, tariff, and foreign-exchange pressures tied to its global footprint. Because consumables depend on installed-base utilization, any slowdown in provider adoption or treatment volume can weaken recurring demand.
- Competitive pressure in beauty health and medical aestheticsImpact: HighLikelihood: Medium
The market is fragmented and rivals offer similar devices and treatments at aggressive prices.
Exposure - Regulatory and claims substantiation riskImpact: HighLikelihood: Medium
FDA, FTC, and foreign regulators can challenge marketing claims or product classifications.
Exposure - Product safety and recall riskImpact: HighLikelihood: Medium
Adverse events or device defects can trigger reporting obligations, recalls, and reputational damage.
Exposure: Device reliability and clinical use
- International and supply-chain exposureImpact: MediumLikelihood: High
Global sourcing and distribution create exposure to tariffs, logistics disruptions, and currency moves.
Exposure: Manufacturing inputs and overseas sales
Accounting
Judgemental itemsShipment-based recognition can shift revenue between periods when orders or channel inventory change.
Impact: Quarterly comparability and reported growth rates
Management estimates resale value, refurbishment cost, and margin for returned devices.
Impact: Revenue, inventory carrying value, and gross profit
Acquired assets are tested for recoverability using forecast-driven valuation models.
Impact: Potential non-cash impairment charges
Cumulative losses affect whether future tax benefits are considered realizable.
Impact: Income tax expense and net deferred tax assets
Similar listed companies
Publicly listed companies with a comparable business focus.
Skinvisible, Inc.
SKVI · Pharmaceutical Preparations
BioScience Health Innovations, Inc.
BHIC · Services-Computer Processing & Data Preparation
Longevity Health Holdings, Inc.
XAGE · Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
InfuSystem Holdings, Inc
INFU · Surgical & Medical Instruments & Apparatus
Hims & Hers Health, Inc.
HIMS · Services-Offices & Clinics of Doctors of Medicine
Sensus Healthcare, Inc.
SRTS · Surgical & Medical Instruments & Apparatus
Last updated: 24/09/2026